Interesting discussion today and kinda quirky. Def
Post# of 148278
For those who think 100 per share is a slam dunk, the last conference call provided some reality. HIV looks good, but even Dr. Jay said leronlimab would be really great in combo with another drug I think because of the random viral load spikes every once in awhile???(don't quote me on that) also in cancer the other "slam dunk" they aren't see what they want YET. I don't know what markers they are looking for here, and we have had some promising lowering of CTC levels. Very good indeed, but IMMU had to get all the way to phase 3 and the FDA to halt trial on good news before someone stepped up to buyout. We will take awhile to get their and IF covid/hiv take longer than we hope for approval, there's going to be more painful dilution on the horizon.
I personally can wait that out because I have not invested anything I can't lose, but if we got up into the 20's and 30's I would have no qualms about taking my ball and going home because I would be comfortably set up(and I know no one would miss me here :o) ). Whoever buys my shares at that price, good luck to them and if it hits 100, that would be awesome, but I certainly am not going to condemn someone for taking a profit at any price for them. Its kinda what investing is about.
My 2 cents I accept any thumbs down.